Esprinet Spa Stock Price To Earnings To Growth
| EP4A Stock | EUR 4.27 0.19 4.66% |
Esprinet SpA fundamentals help investors to digest information that contributes to Esprinet SpA's financial success or failures. It also enables traders to predict the movement of Esprinet Stock. The fundamental analysis module provides a way to measure Esprinet SpA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Esprinet SpA stock.
Esprinet |
Esprinet SpA Company Price To Earnings To Growth Analysis
Esprinet SpA's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Esprinet SpA has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Technology sector and about the same as Electronics & Computer Distribution (which currently averages 0.0) industry. The price to earnings to growth for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Esprinet Fundamentals
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0262 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 732.76 M | |||
| Shares Outstanding | 49.41 M | |||
| Shares Owned By Insiders | 41.81 % | |||
| Shares Owned By Institutions | 33.09 % | |||
| Price To Earning | 18.65 X | |||
| Price To Book | 0.87 X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 4.69 B | |||
| Gross Profit | 231.89 M | |||
| EBITDA | 82.52 M | |||
| Net Income | 44.18 M | |||
| Cash And Equivalents | 180.61 M | |||
| Cash Per Share | 3.66 X | |||
| Total Debt | 106.53 M | |||
| Debt To Equity | 0.81 % | |||
| Current Ratio | 1.38 X | |||
| Book Value Per Share | 7.79 X | |||
| Cash Flow From Operations | 21.65 M | |||
| Earnings Per Share | 0.82 X | |||
| Number Of Employees | 1.77 K | |||
| Beta | 1.39 | |||
| Market Capitalization | 353.99 M | |||
| Total Asset | 1.92 B | |||
| Z Score | 3.8 | |||
| Annual Yield | 0.08 % | |||
| Net Asset | 1.92 B | |||
| Last Dividend Paid | 0.54 |
About Esprinet SpA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Esprinet SpA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Esprinet SpA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Esprinet SpA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Esprinet Stock
Esprinet SpA financial ratios help investors to determine whether Esprinet Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Esprinet with respect to the benefits of owning Esprinet SpA security.